«Patients
using calcineurin inhibitors can potentially experience many adverse effects.
Not exact matches
For example, CRAC channels in T cells have been clinically validated as important drug targets through human mutations and the
use of
calcineurin inhibitors that act downstream from CRAC channels.
• Proactive management includes the intermittent, but scheduled
use of topical corticosteroids or topical
calcineurin inhibitors to areas of the body that frequently have recurrent disease.